The first Compass Therapeutics trade was made in Q1 2022.
Since then Jim Simons bought shares eight more times and sold shares on seven occasions. The investor completely sold their stake between Q2 2025 and Q4 2025.
Avg closing price
Price range
Sold -79k shares
Q4 2025
Avg closing price
$4.63
Price range
$3.36
-
$5.79
Sold 64.8% shares (-146k shares)
Q3 2025
Avg closing price
$3.16
Price range
$2.58
-
$3.82
Sold 30.1% shares (-96.9k shares)
Q2 2025
Avg closing price
$2.06
Price range
$1.46
-
$2.69
Increased shares by 15.4% (+42.9k shares)
Q1 2025
Avg closing price
$2.66
Price range
$1.40
-
$3.90
Increased shares by 25.2% (+56k shares)
Q4 2024
Avg closing price
$1.65
Price range
$1.35
-
$1.98
Increased shares by 58.3% (+82k shares)
Q3 2024
Avg closing price
$1.19
Price range
$0.80
-
$1.88
Increased shares by 99.7% (+70.2k shares)
Q2 2024
Avg closing price
$1.46
Price range
$1.00
-
$1.85
Sold 60.2% shares (-106k shares)
Q1 2024
Avg closing price
$1.73
Price range
$1.20
-
$2.29
Increased shares by 559.7% (+150k shares)
Q4 2023
Avg closing price
$1.73
Price range
$1.40
-
$1.98
New holding (+26.8k shares)
Q3 2023
Avg closing price
$2.47
Price range
$1.87
-
$3.25
Sold -52.3k shares
Q2 2023
Avg closing price
$3.14
Price range
$2.64
-
$3.48
Increased shares by 0.8% (+400 shares)
Q1 2023
Avg closing price
$3.93
Price range
$3.14
-
$5.48
Sold 19.2% shares (-12.3k shares)
Q4 2022
Avg closing price
$3.99
Price range
$2.55
-
$5.41
Sold 2.9% shares (-1.95k shares)
Q3 2022
Avg closing price
$2.77
Price range
$1.90
-
$3.37
Increased shares by 397.5% (+52.9k shares)
Q2 2022